RNA aptamers in sepsis therapy
Aptamers are special nucleic acids with structural characteristics which allow them to bind to a specific protein as a target molecule. Selected RNA aptamers with a characteristic lead structure already exist, which bind specifically to the murine, lipopolysaccharide-binding protein (mLBP). This protein LBP plays a key role during septic shock and is linked to the LPS-induced signalling cascade. The selected RNA aptamers constitute valuable molecular tools in sepsis research and fulfil the preconditions for the development of new diagnostic and therapeutic medicines for the treatment of septic shock.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Recovering phosphorus from sewage sludge ash
Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…